In 2023, sales of blood and blood-forming organs medicines in the UK stood at 1.57 billion pounds. Between 2024 and 2028, forecasted sales show a steady year-on-year growth of approximately 3% annually, culminating in a value of 1.82 billion pounds by 2028. The compound annual growth rate for this period is estimated at 3.08%, reflecting a consistent upward trend driven by ongoing medical advancements and an aging population requiring increased healthcare interventions.
Future trends to watch include:
- Increased demand due to aging demographics and associated chronic conditions.
- Continued innovation in drug formulations and personalized medicine.
- Potential impacts from economic conditions and healthcare policy changes.
